D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$820M |
| 2 |
Visa
V
|
+$667M |
| 3 |
HES
Hess
HES
|
+$515M |
| 4 |
Mastercard
MA
|
+$425M |
| 5 |
Oracle
ORCL
|
+$382M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.03B |
| 2 |
Advanced Micro Devices
AMD
|
+$949M |
| 3 |
Citigroup
C
|
+$419M |
| 4 |
ExxonMobil
XOM
|
+$391M |
| 5 |
Booking.com
BKNG
|
+$349M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 40.59% |
| 2 | Technology | 18.36% |
| 3 | Consumer Discretionary | 9.46% |
| 4 | Financials | 6.95% |
| 5 | Healthcare | 6.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2126
Angi Inc
ANGI
$215M
| $3.21M | ﹤0.01% |
122,486
+30,974
| +34% | +$789K |
|
2127
Triumph Financial Inc
TFIN
$1.51B
| $3.21M | ﹤0.01% |
40,449
+982
| +2% | +$74.2K |
|
2128
CALL
Cleveland-Cliffs
CLF
$7.13B
| $3.2M | ﹤0.01% |
140,600
-492,300
| -78% | -$9.76M |
|
2129
Apogee Enterprises
APOG
$768M
| $3.2M | ﹤0.01% |
53,985
-5,028
| -9% | -$278K |
|
2130
Eldorado Gold
EGO
$11.3B
| $3.19M | ﹤0.01% |
226,712
-87,573
| -28% | -$1.06M |
|
|
MPT
2131
Medical Properties Trust
MPT
$2.03B
| $3.19M | ﹤0.01% |
+678,236
| New | +$2.6M |
|
2132
Southwest Airlines
LUV
$20B
| $3.18M | ﹤0.01% |
109,055
+100,967
| +1,248% | +$3.13M |
|
2133
PUT
Teladoc Health
TDOC
$1.14B
| $3.18M | ﹤0.01% |
210,800
+150,100
| +247% | +$2.72M |
|
2134
American Tower
AMT
$81.1B
| $3.18M | ﹤0.01% |
16,078
+13,378
| +495% | +$2.66M |
|
2135
Opko Health
OPK
$1.25B
| $3.18M | ﹤0.01% |
2,646,084
-3,196,453
| -55% | -$3.2M |
|
|
PGRE
2136
DELISTED
Paramount Group
PGRE
| $3.16M | ﹤0.01% |
674,216
+125,715
| +23% | +$592K |
|
2137
CALL
Lemonade
LMND
$3.64B
| $3.15M | ﹤0.01% |
+192,200
| New | +$3.23M |
|
2138
PUT
NETGEAR
NTGR
$590M
| $3.15M | ﹤0.01% |
+200,000
| New | +$2.91M |
|
2139
Brinker International
EAT
$8.22B
| $3.14M | ﹤0.01% |
63,160
+39,118
| +163% | +$1.73M |
|
2140
Nuvation Bio
NUVB
$2.05B
| $3.13M | ﹤0.01% |
860,940
+346,010
| +67% | +$664K |
|
2141
CALL
Martin Marietta Materials
MLM
$34.8B
| $3.13M | ﹤0.01% |
5,100
| – | – |
|
2142
PUT
Oshkosh
OSK
$9.05B
| $3.12M | ﹤0.01% |
25,000
-48,600
| -66% | -$5.41M |
|
2143
Columbia Sportswear
COLM
$2.91B
| $3.12M | ﹤0.01% |
+38,390
| New | +$3.05M |
|
2144
PUT
Cadence Design Systems
CDNS
$77.9B
| $3.11M | ﹤0.01% |
+10,000
| New | +$2.96M |
|
2145
PUT
AngloGold Ashanti
AU
$52.2B
| $3.11M | ﹤0.01% |
140,000
-97,300
| -41% | -$1.83M |
|
2146
Fidelity MSCI Energy Index ETF
FENY
$2.14B
| $3.09M | ﹤0.01% |
+119,420
| New | +$2.81M |
|
2147
Zions Bancorporation
ZION
$9.52B
| $3.09M | ﹤0.01% |
71,174
-12,442
| -15% | -$513K |
|
2148
First Internet Bancorp
INBK
$243M
| $3.09M | ﹤0.01% |
88,898
-9,959
| -10% | -$301K |
|
2149
CVR Energy
CVI
$5.4B
| $3.09M | ﹤0.01% |
+86,551
| New | +$2.87M |
|
2150
AXT Inc
AXTI
$4.59B
| $3.07M | ﹤0.01% |
669,730
+160,045
| +31% | +$544K |
|
Similar funds
D.E. Shaw & Co's Q1 2024 Portfolio in Review
As of Q1 2024, D.E. Shaw & Co held 4,923 positions worth $117B, up 2.1% from $114B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
D.E. Shaw & Co's Q1 2024 filing shows 655 new, 1,367 increased, 1,722 reduced and 634 closed positions. Its largest new stake was Arm: 2,379,839 shares worth $297M. The largest sale was NVIDIA, an estimated $1.03B.
By sector, the portfolio is most concentrated in Miscellaneous at 41% of assets, down from 46% a quarter earlier, followed by Technology and Consumer Discretionary.
- D.E. Shaw & Co's largest Q1 2024 buy was Arm: 2,379,839 shares worth $297M.
- D.E. Shaw & Co added most to Apple in Q1 2024, an estimated $820M increase.
- D.E. Shaw & Co's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $1.03B.
- D.E. Shaw & Co fully exited iShares JPMorgan USD Emerging Markets Bond ETF in Q1 2024, selling an estimated $307M.
- D.E. Shaw & Co's ten largest holdings make up 13% of its $117B portfolio in Q1 2024.
- D.E. Shaw & Co opened 655 new positions and closed 634 in Q1 2024.
- D.E. Shaw & Co's portfolio value rose 2.1% quarter-over-quarter to $117B.
Based on D.E. Shaw & Co's 13F filing for Q1 2024, filed 15 May 2024.